VIEW
IN BROWSER
EDITOR'S
NOTE: Big4Bio
newsletters will not be published from May
22nd-25th; they will resume distribution on
Tuesday, May 26th.
|
 |
|
May 21, 2026 |
| Regional
intelligence on Drugs, Diagnostics,
Devices & Digital Health |
|
|
|
* may need subscription to view |
|
BIG4BIO
WEEKLY CEO Q&A:
Sean A. McCarthy, CEO & Chairman,
CytomX Therapeutics |
| In
this Q&A, McCarthy reflects on the
origin of CytomX's differentiated
scientific vision, clinical and strategic
milestones that define the company's
progress, what it takes to sustain a
high-performing team through uncertainty,
and why he remains optimistic about the
future of oncology innovation. More |
|
|
- Bayer: KERENDIA (finerenone) Granted
Priority Review of Supplemental New Drug
Application by U.S. FDA for Treatment of
Adults With Type 1 Diabetes and Chronic Kidney
Disease More
More*
- Cognition Therapeutics: Completes Meeting
With FDA for Zervimesine (CT1812) in Dementia
With Lewy Bodies With Psychosis More
- Eisai: Deepens Body of Clinical Evidence for
LENVIMA (Lenvatinib) Across Established
Indications at ASCO 2026 More
- Flatiron: New Research Confirms Data Quality
as the Defining Priority Across the Real-World
Evidence Landscape
More
- HUTCHMED and Innovent: NMPA Approval
for ELUNATE (Fruquintinib) in Combination
With TYVYT (Sintilimab Injection) for the
Treatment of Patients With Locally Advanced
or Metastatic Renal Cell Carcinoma More
- Johnson & Johnson: Advances Creation of
Global Intelligent OR Network in Collaboration
With Department of Health - Abu Dhabi
More
- Medscape: Partners With City of Hope to
Enhance Oncology Content and Insights for
Clinicians Worldwide More
- MiNK Therapeutics: New Data on agenT-797, an
allo-iNKT Cell Therapy at ATS 2026;
Simultaneously Published in Clinical
Immunology Communications More
- Oligomerix: Completes Ph 1a Clinical Study
on OLX-07010 More
- Remepy: Strong Clinical Phase IIa
Results for Hybridopa, a First-in-Class
Hybrid Drug for Parkinson’s Disease More
More*
|
|
- LSN: Hot Investor Mandates (Updated 5/19) More
- More on Neurosoft Bioelectronics Garnering
$7.5M for Brain-Computer Interface Technology
More
- More on Roivant Sharing RA Data for Its
Successor More*
More*
|
|
- More on BMS Tapping Anthropic’s
Claude for Enterprise-Wide AI Adoption to
Speed R&D, Global Workflows More
More
More
More*
- More on Pfizer Moving Next-Gen
Vaccine Into Phase III In Prevnar Lifecycle
Strategy More*
More* More*
More
- Radio-pharmaceuticals Are Changing
the Rules of Cancer Therapy More
- Subscribe to LifeSci Startup for
Updates on US Startups More
|
|
- AI in Biotech: The New Frontier for
Leadership & Strategy More
- Andrea Pfeifer Ends 23-Year Reign at AC
Immune; Acadia’s Top R&D Exec Announces
Retirement More*
- Empowering Students Through STEM: A
Conversation With Massachusetts Science &
Engineering Fair Executive Director Helen
Rosenfeld More
- From Seed to Series C: What Investors Look
for Beyond the Science More
- Hiring Outlook: Job Opportunities on
BioSpace Rise YOY, but Layoffs Affect
Thousands More
- More Than Executive Search: Building
Leadership for Every Stage of Growth More
|
|
|
DISCOVER COMPANIES |
|
Big4Bio: NYC Life Science Company
Directory |
|
Locate a specific company or
explore new companies in life
science. |
|
Explore
our Company Directory
|
Provided courtesy
of
 |
|
|
|
 |
|
|
|
You are
receiving this email because
you signed up for one of our
newsletters at Big4Bio.com,
signed up at one of our
partner or sponsor events,
or given as a gift
subscription by your firm or
organization. Unsubscribe
Big4Bio:NYC,
all rights reserved 2026
© 2026
Big4Bio, a division of
BigBio Communications. All
rights reserved.
|
|
|
|
|
